J&J's rising sales face currency hits in 2014, 2015
This article was originally published in Scrip
Executive Summary
Johnson & Johnson emphasized its 2014 sales growth and investments in innovation to boost revenue further in 2015 and beyond, but the company's stock took a hit based on projections that this year's sales increases will be offset by foreign currency impacts.